Paper23602467
Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings?
Chakravarti A and 3 others. Braz J Infect Dis, 2013. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings? Papers, record 23602467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23602467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings?
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Hepatitis C | Major topic |
| Hepatitis C Antigens | Major topic |
| RNA, Viral | Major topic |
| Viral Core Proteins | Major topic |
| Humans | |
| India | |
| Predictive Value of Tests | |
| Reproducibility of Results | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Sensitivity and Specificity | |
| Viral Load |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16023971 | Use of virologic assays in the diagnosis and management of hepatitis C virus infection. | Clin Liver Dis | 2005 | https://conductscience.org/library/papers/16023971 | PubMed |
| 2 | 12433562 | Alternatives to nucleic acid testing in the blood transfusion service. | Lancet | 2002 | https://conductscience.org/library/papers/12433562 | PubMed |
| 3 | 12049856 | The UK blood transfusion service: over a (patent) barrel? | Lancet | 2002 | https://conductscience.org/library/papers/12049856 | PubMed |
| 4 | 15071017 | Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users. | J Clin Microbiol | 2004 | https://conductscience.org/library/papers/15071017 | PubMed |
| 5 | 7595353 | Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. | J Gen Virol | 1995 | https://conductscience.org/library/papers/7595353 | PubMed |
| 6 | 17569145 | Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17569145 | PubMed |
| 7 | 15653411 | The role of core antigen detection in management of hepatitis C: a critical review. | J Clin Virol | 2005 | https://conductscience.org/library/papers/15653411 | PubMed |
| 8 | 17163874 | Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India. | Transfus Med | 2006 | https://conductscience.org/library/papers/17163874 | PubMed |
| 9 | 15057920 | Diagnosis, management, and treatment of hepatitis C. | Hepatology | 2004 | https://conductscience.org/library/papers/15057920 | PubMed |
| 10 | 16081925 | Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16081925 | PubMed |
| 11 | 16327131 | Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: a study from Northern India. | Indian J Med Microbiol | 2005 | https://conductscience.org/library/papers/16327131 | PubMed |
| 12 | 12085367 | Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. | Hepatology | 2002 | https://conductscience.org/library/papers/12085367 | PubMed |
| 13 | 20351215 | New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. | J Clin Microbiol | 2010 | https://conductscience.org/library/papers/20351215 | PubMed |
| 14 | 20233674 | Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. | J Clin Virol | 2010 | https://conductscience.org/library/papers/20233674 | PubMed |
| 15 | 72251 | Acute and chronic hepatitis revisited. Review by an international group. | Lancet | 1977 | https://conductscience.org/library/papers/72251 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39497140 | Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis. | Virol J | 2024 | https://conductscience.org/library/papers/39497140 | PubMed |
| 35535106 | Laboratory Evaluation of Hepatitis C Virus Infection in Patients Undergoing Hemodialysis from North East India. | J Clin Exp Hepatol | 2022 | https://conductscience.org/library/papers/35535106 | PubMed |
| 33788295 | HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. | J Clin Lab Anal | 2021 | https://conductscience.org/library/papers/33788295 | PubMed |
| 33605377 | Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting. | Rev Soc Bras Med Trop | 2021 | https://conductscience.org/library/papers/33605377 | PubMed |
| 33187498 | Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. | BMC Nephrol | 2020 | https://conductscience.org/library/papers/33187498 | PubMed |
| 30855495 | HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/30855495 | PubMed |
| 27493460 | Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. | J Clin Exp Hepatol | 2016 | https://conductscience.org/library/papers/27493460 | PubMed |
| 26900280 | Hepatobiliary Quiz (Answers)-16 (2015). | J Clin Exp Hepatol | 2015 | https://conductscience.org/library/papers/26900280 | PubMed |
| 26628840 | Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. | J Clin Exp Hepatol | 2015 | https://conductscience.org/library/papers/26628840 | PubMed |
| 25755549 | Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. | J Clin Exp Hepatol | 2014 | https://conductscience.org/library/papers/25755549 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23602467
GET https://conductscience.org/api/papers/v1/23602467/authors